Variation in pre-PCR processing of FFPE samples leads to discrepancies inBRAFandEGFRmutation detection: a diagnostic RING trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Variation in pre-PCR processing of FFPE samples leads to discrepancies inBRAFandEGFRmutation detection: a diagnostic RING trial
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 68, Issue 2, Pages 111-118
Publisher
BMJ
Online
2014-11-28
DOI
10.1136/jclinpath-2014-202644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
- (2014) S Patton et al. BRITISH JOURNAL OF CANCER
- A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer
- (2014) Khashayar Esfahani et al. Frontiers in Oncology
- Current Landscape and New Paradigms of Proficiency Testing and External Quality Assessment for Molecular Genetics
- (2013) Lisa V. Kalman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Fragmentation of DNA affects the accuracy of the DNA quantitation by the commonly used methods
- (2013) Tatiana Sedlackova et al. BIOLOGICAL PROCEDURES ONLINE
- Expression Analysis on Archival Material Revisited
- (2013) Christophe Deben et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
- (2013) Michele Simbolo et al. PLoS One
- Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies
- (2013) Sachin Sah et al. Genome Medicine
- EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
- (2012) A W Langerak et al. LEUKEMIA
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Technical note: Comparative analyses of the quality and yield of genomic DNA from invasive and noninvasive, automated and manual extraction methods
- (2011) C. Foley et al. JOURNAL OF DAIRY SCIENCE
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations
- (2010) Athanasios C. Tsiatis et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation